XPhyto reports market and product developments on platform-based Rotigotine transdermal patch for Parkinson’s disease
Apr 4, 2022
Vancouver, Canada, and Uttenweiler, Germany (April 4, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide...